$2.38
+0.07 (+3.03%)
Open$2.37
Previous Close$2.31
Day High$2.38
Day Low$2.31
52W High$7.33
52W Low$2.05
Volume—
Avg Volume207.8K
Market Cap37.40M
P/E Ratio—
EPS$-0.78
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+1,474.8% upside
Current
$2.38
$2.38
Target
$37.48
$37.48
$21.76
$37.48 avg
$51.92
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 19.67M | 30.23M | 6.59M |
| Net Income | -44,039,181 | -60,902,370 | 1.64M |
| Profit Margin | -223.9% | -212.7% | 24.9% |
| EBITDA | -42,694,138 | -62,322,420 | 3.19M |
| Free Cash Flow | — | — | 1.30M |
| Rev Growth | -34.9% | -34.9% | +19.2% |
| Debt/Equity | — | — | 0.45 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |